Neurosoft Bioelectronics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.5M

  • Investors
  • 18

Neurosoft Bioelectronics General Information

Description

Developer of soft implantable electrodes intended to diagnose and treat neurological diseases by recording or electrically stimulating neural tissues. The company's technology develops compliant neural interfaces that can achieve long-term bio-integration in the body by conforming to the static and dynamic mechanics of neural tissue, enabling doctors to improve therapeutic outcomes in patients and open up new applications for neural interfaces.

Contact Information

Website
neurosoft-bio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Campus Biotech
  • Chemin des Mines 9
  • 1202 Geneva
  • Switzerland
+41 078
Primary Industry
Therapeutic Devices
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Campus Biotech
  • Chemin des Mines 9
  • 1202 Geneva
  • Switzerland
+41 078

Neurosoft Bioelectronics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurosoft Bioelectronics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC 20-May-2026 $7.5M Completed Generating Revenue
12. Later Stage VC Completed Generating Revenue
11. Later Stage VC 27-Feb-2024 Completed Generating Revenue
10. Accelerator/Incubator Completed Generating Revenue
9. Accelerator/Incubator 01-May-2023 Completed Generating Revenue
8. Early Stage VC 05-Apr-2022 Completed Generating Revenue
7. Early Stage VC (Series A) 28-Jan-2021 Cancelled Startup
6. Accelerator/Incubator 29-Apr-2021 Completed Startup
5. Seed Round 31-Jan-2021 $113K $155K Completed Startup
4. Seed Round 24-Jun-2020 $41.9K $41.9K Completed Startup
To view Neurosoft Bioelectronics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Neurosoft Bioelectronics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of soft implantable electrodes intended to diagnose and treat neurological diseases by recording or electrical
Therapeutic Devices
Geneva, Switzerland
20 As of 2026

Milan, Italy
 

Freiburg, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neurosoft Bioelectronics Competitors (2)

One of Neurosoft Bioelectronics’s 2 competitors is WISE (Therapeutic Devices), a Venture Capital-Backed company based in Milan, Italy.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
WISE (Therapeutic Devices) Venture Capital-Backed Milan, Italy
CorTec Venture Capital-Backed Freiburg, Germany
You’re viewing 2 of 2 competitors. Get the full list »

Neurosoft Bioelectronics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurosoft Bioelectronics Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Connecticut Innovations Venture Capital Minority
Ecosystem Ventures Venture Capital Minority
IAG Capital Partners Venture Capital Minority
Kamiot PE/Buyout Minority
Plug and Play Accelerator/Incubator Minority
You’re viewing 5 of 18 investors. Get the full list »

Ready to get started?

Request a free trial

Neurosoft Bioelectronics FAQs

  • When was Neurosoft Bioelectronics founded?

    Neurosoft Bioelectronics was founded in 2019.

  • Where is Neurosoft Bioelectronics headquartered?

    Neurosoft Bioelectronics is headquartered in Geneva, Switzerland.

  • What is the size of Neurosoft Bioelectronics?

    Neurosoft Bioelectronics has 20 total employees.

  • What industry is Neurosoft Bioelectronics in?

    Neurosoft Bioelectronics’s primary industry is Therapeutic Devices.

  • Is Neurosoft Bioelectronics a private or public company?

    Neurosoft Bioelectronics is a Private company.

  • What is Neurosoft Bioelectronics’s current revenue?

    The current revenue for Neurosoft Bioelectronics is .

  • How much funding has Neurosoft Bioelectronics raised over time?

    Neurosoft Bioelectronics has raised $19.9M.

  • Who are Neurosoft Bioelectronics’s investors?

    Connecticut Innovations, Ecosystem Ventures, IAG Capital Partners, Kamiot, and Plug and Play are 5 of 18 investors who have invested in Neurosoft Bioelectronics.

  • Who are Neurosoft Bioelectronics’s competitors?

    WISE (Therapeutic Devices) and CorTec are competitors of Neurosoft Bioelectronics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process